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Effect and Mechanism of Tamoxifen on Peritoneal Fibrosis in Mice
Undergoing Peritoneal Dialysis
Xiang Zhao
Zhejiang Province People’s Hospital, Hangzhou, Zhejiang, China
Objective: To investigate the effect and the perhaps mechanism of tamox-
ifen on peritoneal dialysis related peritoneal fibrosis.
Methods: Intraperitoneal injected with 4.25% glucose peritoneal dialysis
fluid to establish a mouse model of peritoneal fibrosis. C57BL/6 male mouse
were randomly divided into three groups: control group; high-glucose perito-
neal fluid group (PDF group), and tamoxifen group (TAX group). Histologic
changes were examined by Masson’s trichrome stain. Expression of Wnt4,
b-catenin, E-cadherin, NF-kB, COL1A1, cytokeratin protein were evaluated
by immunofluorescence staining and Western Blot.
Results: A light microscope Masson’s trichrome stain showed the peritonum
of mouse in PDF group are significantly thicker than control group; the
tamoxifen treatment ameliorated the thickening of peritoneum induced by
PDF. Immunofluorescence staining and Western Blot showed that protein
expression of Wnt4, b-catenin, NK-kB, COL1A1 increased in PDF group than
in control group (all P < 0.05), protein expression of E-cadherin and basic
cytokeratin decreased in PDF group than in control group (all P < 0.05).
The tamoxifen treatment ameliorated the increased expression of Wnt4,
b-catenin, NK-kB, COL1A1 induced by PDF and the expression of E-cadherin
and basic cytokeratin decreased than in PDF group.
Conclusion: Peritoneal dialysis related peritoneal fibrosis may mediated by
the activation of Wnt / b-catenin signaling pathway in mouse peritonum, and
tamoxifen can ameliorated peritoneal fibrosis possibly by inhibiting the Wnt
/ b-catenin signaling pathway.http://dx.doi.org/10.1016/j.hkjn.2015.09.180
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Efficacy of Low-dose Bisoprolol in Maintenance Hemodialysis Patients
with Asymptomatic Left Ventricular Diastolic Dysfunction
Wei Shen, Qiang He, Yiwen Li
Kidney Disease Center, Zhejiang Province People’s Hospital, Hangzhou,
Zhejiang, China
Objective: Left ventricular hypertrophy and diastolic dysfunction are the most
frequent cardiac alteration in ESRD. The aim of this study was to determine
whether the b-blocker, bisoprolol, has beneficial effects inmaintenance hemo-
dialysis patients with asymptomatic left ventricular diastolic dysfunction.
Methods: In this study we enrolled 120 patients with chronic kidney disease
(CKD) undergoingmaintenancehemodialysis accompanying left ventricular dia-
stolic dysfunction more than six months. Bisoprolol was started with 1.25 mg
once daily orally 30 minutes after breakfast and increased every 1 week by
1.25 mg increments up to the maximum tolerated dose. Echocardiographic ex-
amination was used to measurement of left ventricular diastolic function.
Results: 108 patients finished 6 months study. After 6 months of treatment,
compared with the baseline, the cardiothoracic ratio was significant
decreased. Echocardiographic examination showed that there was no signif-
icant change in EF, but LVDd, LVDs, PWT were significant decreased. E/A ra-
tio was significantly increased.
Conclusion: Our study demonstrate bisoprolol efficacy in improving left ven-
tricular diastolic dysfunction in HD patient with normal blood pressure.http://dx.doi.org/10.1016/j.hkjn.2015.09.1810109
Effect of Hemodialysis on Anterior Chamber Biometric Structure and
Intraocular Pressure in Non-Diabetic Patients with End-stage Renal
Disease
Wei Shen, Qiang He, Yiwen Li
Kidney Disease Center, Zhejiang Province People’s Hospital, Hangzhou,
Zhejiang, China
Objective: To evaluate the short-term changes in the ophthalmologic find-
ings after low-flux hemodialysis in non-diabetic end-stage chronic renal fail-
ure (CRF) patients.
Methods: Forty-three patients (86 eyes) selected so as not to have glaucoma or
history of glaucomawere studied. We observed the patients onmaintenance he-
modialysis therapymore than6months. Their clinical characteristics andmedical
recordsbeforeandafterhemodialysiswere reviewedthroughthewayof self-con-
trol study. Detailed ophthalmologic examinations together with tomometre
(intraocular pressure, IOP), A/B scan (lens thickness) and ultrasound bio-
microscopy (central anterior chamber depth) were performed immediately
beforeandafterHDsessions.Demographic information includingage, gender,un-
derling systemicdiseases,hemodialysisduration,and levelsofbodyweight,blood
urea nitrogen, and creatinine before and after hemodialysis were recorded.
Results: The mean age of the patients at the time of dialysis was 49.7 12.0
(range 33 to 65) years. 53.5% (23) were men. After hemodialysis treatment,
the blood urea nitrogen, creatinine, patient weight decreased significantly
(P < 0.01). There was no significant difference in the change in serum cal-
cium, serum phosphorus, serum albumin and hemoglobin after treatment
(P > 0.05). Mean central anterior chamber depth also decreased significantly
after HD, from 2.46 0.38 to 2.38 0.36 mum (paired t test, P < 0.01).
Mean lens thickness significantly increased from 4.23 0.22 mm before HD
to 4.30 0.12 mm after HD (P < 0.01) in group. However, Mean IOP
increased from 12.32 4.31 mmHg to 14.31 2.98 mmHg after HD (paired
t test, P < 0.01).
Conclusion:Conventional hemodialysis can affect the ophthalmologic findings.
Patients with chronic renal failure should be checked of their anterior chamber
structure and be given corresponding treatment before haemodialysis.http://dx.doi.org/10.1016/j.hkjn.2015.09.182
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miRNA-143/145 Gene Cluster Enhances Cell Deformation and Fibrosis of
Human Peritoneal Mesothelial Cells via Modulating TPM4
Lijie He, Jinping Hu, Tiantian Shi
Department of Nephrology, Xi’an, China
Objective: This work for the function and mechanism of miR-143/145 gene
cluster in human peritoneal mesothelial cells (HPMC).
Methods: To investigate if miR-143/145 gene cluster could promote PM
fibrosis, all these immortal and cast-off HPMCs from the effluents of
end-stage renal disease (ESRD) patients with peritoneal dialysis (PD)
were characterized by fibrosis related markers and tested the expression
of miRNA-143/145 cluster and tropomyosin 4 (TPM4) by real time PCR or
Western blot. We also used PD dialysis rat model to observe the response
of PM to miR-143/145 gene cluster and their possible target.
Results: Here, we found that miR-143/145 gene cluster, which are exam-
ined to be highly expressed in HG-induced HPMCs or in cast-off HPMCs ex
vivo which have a transformed fibroblastic phenotype stimulated by high
glucose (HG, 60 mmol/L) and in PD animal model. TPM4 were found signif-
icantly lower expression in HG-induced HPMCs. So our study showed that
high glucose from PD fluid could promote the expression of miR-143/145
of HPMCs and reduce the expression of TPM4, compared with normal
glucose-cultured HPMCs (Figure 1A-E). Reporter assays further supported
that TPM4 were post-transcriptionally regulated together by miR-143/145
gene cluster. Collectively, these data suggested that TPM4 was a down-
stream target of miR-143/145 gene cluster. Re-expression of miR-143/
145 gene cluster by miR-143 or miR-145 mimic led to cell deformation,
and reduced cell adhesion, following the down-regulating expression of
TPM4 and E-cadherin, but up-regulating expression of a-SMA, CTGF, colla-
gens and fibronectin which might increase PM fibrosis. Depletion of miR-
143/145 cluster in HG-induced HPMCs enhanced cell adhesion, marking
by up-regulating E-cadherin and TPM4 but down-regulating a-SMA, CTGF,
collagens and fibronectin in vitro (Figure 1F).
